<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2608">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04743947</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1237</org_study_id>
    <nct_id>NCT04743947</nct_id>
  </id_info>
  <brief_title>SARS-CoV-2 Vaccination in Chronic Kidney Disease</brief_title>
  <official_title>Observational Study on the Effects of SARS-CoV-2 Vaccination in Dialysis and Kidney Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, observational study that will enroll patients receiving&#xD;
      dialysis (hemodialysis or peritoneal dialysis) or patients with kidney transplantation who&#xD;
      will be vaccinated with SARS-CoV-2- vaccine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients on dialysis and kidney transplant patients infected with SARS-CoV-2 have an&#xD;
      increased risk to develop a more severe course of disease or die from SARS-CoV-2 infection.&#xD;
      SARS-CoV-2 vaccination can increase protection against SARS-CoV-2 infection. Kidney&#xD;
      transplant patients and patients requiring dialysis suffer from an acquired immune&#xD;
      deficiency. Due to the dysfunctional immune response, the general vaccine response in&#xD;
      dialysis patients and kidney transplant patients is in many cases insufficient.&#xD;
&#xD;
      Until now, the vaccination response in dialysis patients and kidney-transplanted patients is&#xD;
      unpredictable. Verification of vaccine response can provide important information on how to&#xD;
      treat and protect these patients from a SARS-CoV-2 infection. Therefore, there is a medical&#xD;
      need to monitor vaccine protection after SARS-CoV-2 vaccination in clinical practice. In this&#xD;
      observational study, data of the SARS-CoV-2 vaccination response collected in clinical&#xD;
      routine will be analyzed from these patients. Based on this observational study, we aim to&#xD;
      get first evidence whether and to what extent SARS-CoV-2 vaccination causes a vaccine&#xD;
      response in immunocompromised patients with kidney disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SARS-CoV-2- antibody- titer</measure>
    <time_frame>2 years</time_frame>
    <description>SARS-CoV-2- antibody- titer after vaccine</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>SARS-CoV-2 Vaccination in Dialysis and Kidney Transplant Patients</condition>
  <arm_group>
    <arm_group_label>Patients with kidney failure receiving dialysis</arm_group_label>
    <description>Analysis of data received from clinical practice about the SARS-CoV-2 vaccination response in dialysis patients (hemodialysis or peritoneal dialysis).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kidney transplant patients</arm_group_label>
    <description>Analysis of data received from clinical practice about the SARS-CoV-2 vaccination response in kidney transplant patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>age-matched controls in non-dialysis, non-kidney transplant patients</arm_group_label>
    <description>Historical cohort of aged machted non-dialysis and non-kidney transplanted patients who received a SARS-CoV-2 vaccination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervaention; observational study</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Kidney transplant patients</arm_group_label>
    <arm_group_label>Patients with kidney failure receiving dialysis</arm_group_label>
    <arm_group_label>age-matched controls in non-dialysis, non-kidney transplant patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are treated in a nephrology in- or out-patient clinic and how are willing to&#xD;
        get a SARS-CoV-2 vaccination.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  receiving dialysis (hemodialysis or peritoneal dialysis)&#xD;
&#xD;
          -  capable of giving consent&#xD;
&#xD;
          -  age 18 or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - non-capable of giving consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Johannes Stegbauer, MD</last_name>
    <phone>+492118117502</phone>
    <email>johannes.stegbauer@med.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claudia Schmidt, PhD</last_name>
    <phone>+492118108074</phone>
    <email>claudia.schmidt@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MVZ DaVita Rhein-Ruhr</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40210</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerd Hetzel, Prof. MD</last_name>
      <phone>0211 16797-30</phone>
      <email>Gerd.Hetzel@davita.com</email>
    </contact>
    <investigator>
      <last_name>Lea Weiland</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerd Hetzel, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seher Küçükköylü, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>KfH Kuratorium für Dialyse und Nierentransplantation e.V.</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Christian Rump, Prof. MD</last_name>
      <phone>0211 876696-0</phone>
      <email>christian.rump@med.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Stegbauer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thilo Kolb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars Christian Rump, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Düsseldorf, Heinrich Heine University</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Stegbauer, MD</last_name>
      <phone>+492118117502</phone>
      <email>johannes.stegbauer@med.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Stegbauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thilo Kolb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars C Rump, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nephrocare Mettmann</name>
      <address>
        <city>Mettmann</city>
        <zip>40822</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Koch, Prof. MD</last_name>
      <phone>02051 4197-0</phone>
      <email>koch@dialyse-mettmann.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Solingen</name>
      <address>
        <city>Solingen</city>
        <zip>42653</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Schmitz, MD</last_name>
      <phone>0212-547-2418</phone>
      <email>schmitz.m@klinikumsolingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2021</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>PD Dr. med. Johannes Stegbauer</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>SARS-CoV-2</keyword>
  <keyword>vaccination</keyword>
  <keyword>diaylsis</keyword>
  <keyword>kidney transplantation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

